Skip to main content
. Author manuscript; available in PMC: 2022 Jul 23.
Published in final edited form as: Eur J Prev Cardiol. 2021 Jul 23;28(8):e12–e14. doi: 10.1177/2047487320931296

Figure 1.

Figure 1.

Distribution of Lp(a) and ASCVD risk scores in adults who experience an MI at a young age (≤50 years). (a) Distribution of Lp(a) assay: 101 out of 352 (29%) patients who underwent the standard immunochemical-based assay had Lp(a) levels ≥50 mg/dL, corresponding to the 80th percentile in the general population. (b) ASCVD risk and Lp(a) level: 71% of patients with Lp(a) levels ≥80th percentile had ASCVD risk scores < 7.5% prior to their MI, thereby demonstrating that there is no association between the calculated ASCVD risk and levels of Lp(a).